Application no. and date | 14722450.5 (espacenet) (Federated) (European Patent Register), 20140314 | Patent/reg. no. and date | DK/EP 2968588, 20190109 | Publication date | 20160120 | Priority no. and date | US 201361790490 P, 20130315 | EP pub. no. and date |
EP 2968588 20160120 | Effective date | | Applicant/owner | AbbVie Inc., 1 North Waukegan Road
North Chicago, IL 60064, US, Abbvie Deutschland GmbH & Co. KG, Max-Planck-Ring 2a
65205 Wiesbaden, DE | Applicant ref. no. | P24150DKEP | Inventor | KUMAR, Vineet, 126 Courtyard Lane
Storrs, CT 06268, US, TSCHOEPE, Markus, Lindenweg 4
67258 Hessheim, DE, KALETA, Katharina, Adolf-Diesterweg-Strasse 107
67071 Ludwigshafen, DE | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | Opponent | | IPC Class | A61K 47/68 (2017.01) , A61K 9/19 (2006.01) , A61P 35/00 (2006.01) | Title | ANTI-EGFR-ANTISTOF-LÆGEMIDDEL-KONJUGAT-FORMULERINGER | Int. application no. | US2014027868 | Int. publication no. | WO2014143765 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|